HEMATOLOGIC DISORDER

Clinical trials for HEMATOLOGIC DISORDER explained in plain language.

Never miss a new study

Get alerted when new HEMATOLOGIC DISORDER trials appear

Sign up with your email to follow new studies for HEMATOLOGIC DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New drug shows promise for controlling rare skin cancers

Disease control Ongoing

This study tests a drug called brentuximab vedotin in 79 people with rare skin lymphomas (ALCL, mycosis fungoides, or lymphomatoid papulosis) that have a marker called CD30. The goal is to see if the drug can shrink or control the cancer. Participants receive the drug every 3 wee…

Matched conditions: HEMATOLOGIC DISORDER

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC

HEMATOLOGIC DISORDER

Get alerted when new HEMATOLOGIC DISORDER trials appear

New drug shows promise for controlling rare skin cancers